Reza Fassihi
Président chez Philadelphia Pharmaceutical Forum
Profil
Reza Fassihi has been a Director of SCOLR Pharma, Inc. since November 2003.
He is a Professor of Biopharmaceutics and Industrial Pharmacy at Temple University, School of Pharmacy, which he joined in 1992.
Postes actifs de Reza Fassihi
| Sociétés | Poste | Début |
|---|---|---|
| Philadelphia Pharmaceutical Forum | Président | - |
| Temple University (Pennsylvania) | Corporate Officer/Principal | 01/01/1992 |
Anciens postes connus de Reza Fassihi
| Sociétés | Poste | Fin |
|---|---|---|
| SCOLR PHARMA INC. | Directeur/Membre du Conseil | 31/03/2009 |
Formation de Reza Fassihi
| University of Brighton | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
SCOLR Pharma, Inc.
 SCOLR Pharma, Inc. Pharmaceuticals: MajorHealth Technology SCOLR Pharma, Inc. is a pharmaceutical company, engages in proprietary and patented Controlled Delivery Technology platforms to develop and commercialize novel prescription, over-the-counter and nutritional products. The company's technology is used to develop dietary supplement products, including combinations of glucosamine and chondroitin, niacin, calcium, and other dietary products. Its lead product candidate is a CDT-based extended release formulation of ibuprofen, an analgesic typically used for the treatment of pain, fever and inflammation. SCOLR Pharma was founded in 1983 and is headquartered in Bellevue, WA. | Health Technology |
| Philadelphia Pharmaceutical Forum |
